Skip to main content
. Author manuscript; available in PMC: 2023 Aug 2.
Published in final edited form as: Stat Biopharm Res. 2022 Aug 2;14(3):270–282. doi: 10.1080/19466315.2022.2081602

Figure 2.

Figure 2.

Nine fixed dose-toxicity scenarios considered in the simulation study. The selected dose combinations for the 3+3 design are highlighted by the dotted arrow line.